Business ❯ Finance ❯ Investment Strategies ❯ Risk Assessment

AI Stocks

Morningstar Touts Bristol-Myers as a Top Deep-Value Pick Despite Patent Overhang

The endorsement underscores a market divided by recent fund exits versus approaching patent and pricing pressure.

BlackRock’s GIP in Advanced Talks to Acquire AES in Deal Topping $38 Billion With Debt